Gene Expression Analysis Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Gene Expression Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Instruments, Services, Others), By Technique (RNA Expression, Promotor Analysis, Protein Expression & Post Translational Modification Expression, Others), By Application (Drug Discovery and Development, Clinical Diagnostics, Biotechnology and Microbiology, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Gene Expression Analysis Market is projected to grow from USD 5.52 Billion in 2025 to USD 8.72 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 7.92%. Gene expression analysis involves the quantitative measurement of messenger RNA levels to assess specific gene activity within biological samples, a process essential for elucidating cellular functions and understanding the mechanisms underlying various diseases. This market is primarily supported by the escalating demand for precision medicine and the intensive focus on targeted drug discovery within the pharmaceutical industry. Furthermore, decreasing genomic sequencing costs enable broader adoption for biomarker identification and validation, thereby propelling market growth.
The rising prevalence of chronic conditions, particularly oncology, necessitates robust genomic profiling tools to guide therapeutic decisions, with the American Cancer Society projecting 2,041,910 new cancer cases in the United States in 2025. This substantial disease burden drives the necessity for expression analysis, yet the market faces a significant challenge regarding the interpretation of complex large-scale data. The scarcity of skilled bioinformatics professionals required to analyze these vast datasets serves as a major bottleneck that could impede the full expansion of the Global Gene Expression Analysis Market.
Market Driver
Technological advancements in Next-Generation Sequencing (NGS) and PCR platforms are fundamentally transforming the Global Gene Expression Analysis Market by improving throughput and simplifying genomic profiling. These innovations empower laboratories to process extensive biological data with remarkable speed and accuracy, thereby accelerating the integration of expression analysis into clinical and research environments. High-performance sequencing devices have been a key driver for market expansion, as demonstrated by leading innovators; Oxford Nanopore Technologies reported 23% underlying revenue growth on a constant currency basis in its 2024 annual results, largely due to new sensing platform adoption, while Illumina recorded full-year 2024 revenue of $4.3 billion, highlighting significant global demand for advanced genomic infrastructure.
Furthermore, robust government funding and private investment in genomic research serve as another critical driver, supplying essential capital for scaling precision medicine initiatives and population health studies. Public sector commitments are crucial for biomarker validation and embedding gene expression profiling into national healthcare systems, mitigating risks in new diagnostic tool development. These investments foster a stable growth environment, ensuring long-term project viability, exemplified by the UK Government's significant £650 million investment by 2030 to advance genomic medicine and expand newborn sequencing, which not only speeds up gene-disease association discovery but also mandates broader use of expression analysis technologies in public health.
Market Challenge
The Global Gene Expression Analysis Market is significantly constrained by a scarcity of skilled bioinformatics professionals. Despite the rapid acceleration in genomic data generation, the ability to process and interpret this vast information has lagged, creating a bottleneck where substantial volumes of expression data remain underutilized. This gap delays the conversion of raw sequencing results into actionable biological insights, hindering pharmaceutical companies and research institutions in efficiently validating biomarkers and thereby slowing drug development and clinical applications.
This shortage of specialized talent elevates operational costs and extends project timelines, as organizations compete for a limited pool of experts capable of managing complex high-throughput expression data analysis. According to the Pistoia Alliance in 2025, 34% of life science professionals identified a lack of skilled personnel as a major impediment to adopting advanced data analysis technologies, thus preventing the market from achieving its full scalability across healthcare and research sectors.
Market Trends
The integration of Artificial Intelligence (AI) and Machine Learning (ML) in data analysis is rapidly enhancing market value by transforming intricate genomic datasets into actionable insights. With the exponential growth of gene expression data, AI-driven platforms are increasingly replacing traditional bioinformatics methods, efficiently identifying novel biomarkers and therapeutic targets. This trend validates a commercial model where advanced data interpretation is as crucial as sequencing, directly addressing the challenge of data complexity, as demonstrated by Tempus AI, Inc. reporting total revenue of $693.4 million in 2024, with 30.4% year-over-year growth primarily from algorithmic data services.
Concurrently, the widespread adoption of spatial transcriptomics for tissue mapping is revolutionizing biological research by enabling the visualization of gene activity within the precise physical architecture of tissues. This method overcomes bulk sequencing limitations by maintaining spatial context, which is vital for understanding complex conditions such as the tumor microenvironment. The market is also seeing a significant increase in specialized hardware installations for these high-resolution studies, establishing a lasting infrastructure for single-cell and spatial biology; 10x Genomics, Inc., for instance, reported over 7,000 cumulative instruments sold by the end of 2024, highlighting the growing penetration of these advanced tools in global laboratories.
Key Market Players
* Merck KGaA
* Genscript Biotech Corporation
* Qiagen N.V.
* Bio-Rad Laboratories Inc.
* Takara Bio Inc.
* Thermo Fisher Scientific, Inc.
* Promega Corporation
* Agilent Technologies Inc.
* Lonza Group Ltd.
* New England Biolabs Inc
Report Scope
In this report, the Global Gene Expression Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Gene Expression Analysis Market, By Product Type
* Instruments
* Services
* Others
# Gene Expression Analysis Market, By Technique
* RNA Expression
* Promotor Analysis
* Protein Expression & Post Translational Modification Expression
* Others
# Gene Expression Analysis Market, By Application
* Drug Discovery and Development
* Clinical Diagnostics
* Biotechnology and Microbiology
* Others
# Gene Expression Analysis Market, By End User
* Pharmaceutical and Biotechnology Companies
* Contract Research Organizations (CROs)
* Academic and Government Research Institutes
* Others
# Gene Expression Analysis Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Gene Expression Analysis Market.
Available Customizations:
Global Gene Expression Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Gene Expression Analysis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Instruments, Services, Others)
5.2.2. By Technique (RNA Expression, Promotor Analysis, Protein Expression & Post Translational Modification Expression, Others)
5.2.3. By Application (Drug Discovery and Development, Clinical Diagnostics, Biotechnology and Microbiology, Others)
5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2025)
5.3. Market Map
6. North America Gene Expression Analysis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Technique
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Gene Expression Analysis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Technique
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Gene Expression Analysis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Technique
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Gene Expression Analysis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Technique
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Gene Expression Analysis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technique
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gene Expression Analysis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Technique
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. France Gene Expression Analysis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Technique
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Gene Expression Analysis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Technique
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Gene Expression Analysis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Technique
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Gene Expression Analysis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Technique
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia Pacific Gene Expression Analysis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technique
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Gene Expression Analysis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Technique
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Gene Expression Analysis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Technique
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Gene Expression Analysis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Technique
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Gene Expression Analysis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Technique
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Gene Expression Analysis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Technique
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Middle East & Africa Gene Expression Analysis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technique
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gene Expression Analysis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Technique
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. UAE Gene Expression Analysis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Technique
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. South Africa Gene Expression Analysis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Technique
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Gene Expression Analysis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Technique
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gene Expression Analysis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Technique
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Colombia Gene Expression Analysis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Technique
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Argentina Gene Expression Analysis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Technique
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Gene Expression Analysis Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Merck KGaA
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Genscript Biotech Corporation
15.3. Qiagen N.V.
15.4. Bio-Rad Laboratories Inc.
15.5. Takara Bio Inc.
15.6. Thermo Fisher Scientific, Inc.
15.7. Promega Corporation
15.8. Agilent Technologies Inc.
15.9. Lonza Group Ltd.
15.10. New England Biolabs Inc
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們